(Q36414663)

14 August 2017

1 reference

title

Assessment of GDNF in primate models of Parkinson's disease: comparison with human studies (English)

1 reference

14 August 2017

1 reference

Andisheh Eslamboli

1

1 reference

14 August 2017

1 January 2005

1 reference

Reviews in the Neurosciences

14 August 2017

1 reference

14 August 2017

16

1 reference

14 August 2017

303-310

1 reference

14 August 2017

4

1 reference

Range of neuropsychiatric disturbances in patients with Parkinson's disease

14 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Functional recovery in parkinsonian monkeys treated with GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Localized striatal delivery of GDNF as a treatment for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.4.303

10.1515/REVNEURO.2005.16.4.303

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16519007